Atlas Trials

Study of OT202 in Treating Moderate to Severe Dry Eye

Clinical trial NCT06435182 · COMPLETED

Trial details

NCT number
NCT06435182
Sponsor
Ocumension Therapeutics (Shanghai) Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye
Start date
2023-04-10
Primary completion
2024-01-26
Enrollment
213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.